Total words: 3086 | 2-word phrases: 794 | 3-word phrases: 932 | 4-word phrases: 994
Title | Try to keep the title under 60 characters (73 characters) IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia | Patient Site |
Description | Try to keep the meta description between 50 - 160 characters (191 characters) Learn more about IDHIFA® (enasidenib) for patients with relapsed/refractory acute myeloid leukemia (AML) with an IDH2 mutation. See safety info and BOXED WARNING on differentiation syndrome. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (40 characters) IDHIFA® is the first and only treatment |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | idhifa | 119 | 32.51% | ||||||
2 | your | 90 | 24.59% | ||||||
3 | you | 78 | 21.31% | ||||||
4 | of | 69 | 18.85% | ||||||
5 | to | 68 | 18.58% | ||||||
6 | the | 67 | 18.31% | ||||||
7 | and | 54 | 14.75% | ||||||
8 | for | 53 | 14.48% | ||||||
9 | if | 46 | 12.57% | ||||||
10 | is | 44 | 12.02% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://packageinserts.bms.com/pi/pi_idhifa.pdf | Whois | bms.com |
2 | https://packageinserts.bms.com/pi/pi_idhifa.pdf | Whois | bms.com |
3 | https://packageinserts.bms.com/pi/pi_idhifa.pdf | Whois | bms.com |